Evidence map›Paper›PMID 36139426›Full record

ReviewCells2022

Biomaterials and Extracellular Vesicle Delivery: Current Status, Applications and Challenges.

Kasey S Leung, Sajjad Shirazi, Lyndon F Cooper, Sriram Ravindran

Open access · goldAbstract readReview
In one paragraph

Review in Cells, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
3.1field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Review
  16. Review
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Kasey S LeungDepartment of Oral Biology, College of Dentistry, University of Illinois Chicago, Chicago, IL 60612, USA.ORCID 0000-0003-2437-3656
Sajjad ShiraziDepartment of Oral Biology, College of Dentistry, University of Illinois Chicago, Chicago, IL 60612, USA.ORCID 0000-0002-3996-6772
Lyndon F CooperSchool of Dentistry, Virginia Commonwealth University, Richmond, VA 23298, USA.
Sriram RavindranDepartment of Oral Biology, College of Dentistry, University of Illinois Chicago, Chicago, IL 60612, USA.
University of Illinois Chicago · USVirginia Commonwealth University · US

Funding

3D Encapsulation, Bioprinting and Controlled Delivery of Functionally Engineered EVs (FEEs)R01DE030495 · NIDCR · UNIVERSITY OF ILLINOIS AT CHICAGO · PI COOPER, LYNDON F, GAJENDRAREDDY, PRAVEEN · 2021 to 2025
$2.3M
Mesenchymal stem cell extracellular vesicles for ischemic retinal damageR01EY033902 · NEI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI STEVEN ROTH, Sriram Ravindran · 2022 to 2026
$2.1M
Functional Activation and Targeting of Exosomes for Regenerative MedicineR01DE027404 · NIDCR · UNIVERSITY OF ILLINOIS AT CHICAGO · PI GAJENDRAREDDY, PRAVEEN, RAVINDRAN, SRIRAM · 2018 to 2022
$2.1M
NEI NIH HHS R01 EY033902NIDCR NIH HHS R01 DE027404NIDCR NIH HHS R01 DE030495
6 · The paper itself

Abstract

In this review, we will discuss the current status of extracellular vesicle (EV) delivery via biopolymeric scaffolds for therapeutic applications and the challenges associated with the development of these functionalized scaffolds. EVs are cell-derived membranous structures and are involved in many physiological processes. Naïve and engineered EVs have much therapeutic potential, but proper delivery systems are required to prevent non-specific and off-target effects. Targeted and site-specific delivery using polymeric scaffolds can address these limitations. EV delivery with scaffolds has shown improvements in tissue remodeling, wound healing, bone healing, immunomodulation, and vascular performance. Thus, EV delivery via biopolymeric scaffolds is becoming an increasingly popular approach to tissue engineering. Although there are many types of natural and synthetic biopolymers, the overarching goal for many tissue engineers is to utilize biopolymers to restore defects and function as well as support host regeneration. Functionalizing biopolymers by incorporating EVs works toward this goal. Throughout this review, we will characterize extracellular vesicles, examine various biopolymers as a vehicle for EV delivery for therapeutic purposes, potential mechanisms by which EVs exert their effects, EV delivery for tissue repair and immunomodulation, and the challenges associated with the use of EVs in scaffolds.

Indexed as

Biocompatible MaterialsExtracellular VesiclesTissue EngineeringWound HealingBiocompatible Materialsbiomaterialsbiopolymersextracellular vesiclesmesenchymal stem cellsscaffoldstissue repair

Identifiers

PMID36139426
PMCPMC9497093
OpenAlexW4296747772

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.